TD Cowen has initiated coverage on Qualys Inc stock, assigning a Hold rating and setting a price target of $170.00. The firm recognizes Qualys as one of the top three stand-alone vendors in its sector, noting its strong cash position and capacity to generate leading industry margins. However, Qualys is facing challenges, including a rapid loss of market share and slower revenue growth. The forecast for fiscal year 2024 suggests a slowdown, attributed to increasing competitive pressures within the industry. While Qualys has maintained a solid cash reserve and high-profit margins, competitors are impacting its business performance. The Hold rating reflects a cautious stance on the company's near-term growth prospects, considering the concerns over market share and growth deceleration. Qualys' financial health, with more cash than debt and a gross profit margin of 80.61%, contributes to its ability to maintain high-profit margins. The company's P/E ratio of 40.27 and PEG ratio of 0.86 suggest a favorable relationship between earnings and growth rate. Qualys' next earnings date is set for May 2, 2024.
Cognizant Technology Solutions Co. (NASDAQ:CTSH) has received a consensus recommendation of "Hold" from analysts. One equities research analyst has rated the stock as a sell, thirteen have given a hold rating, and three have issued a buy rating. The average twelve-month price target among brokerages is $75.67. In other news, EVP Kathryn Diaz sold 900 shares of the stock. Institutional investors have also weighed in on Cognizant Technology Solutions, with hedge funds buying and selling shares of the company. The stock's performance has a 1-year low of $61.23 and a 1-year high of $80.09. Cognizant Technology Solutions reported $1.12 EPS for the quarter, beating analysts' consensus estimates of $1.11. The company's quarterly revenue was down 1.1% compared to the same quarter last year. Cognizant Technology Solutions also announced a quarterly dividend of $0.30 per share.
Community Health Systems, Inc. (NYSE:CYH) has received an average rating of "Hold" from the five analysts covering the company. Three analysts have rated the stock as hold, while two have issued a buy rating. The average one-year target price among analysts is $4.05. Several brokerages have recently weighed in on CYH, with Oppenheimer lowering their target price from $5.50 to $4.50 and setting an "outperform" rating. The company reported earnings of ($0.14) per share for the last quarter, beating analysts' consensus estimates of ($0.19) by $0.05. Community Health Systems has a market cap of $494.02 million and a beta of 1.51. The stock has a 1-year low of $2.01 and a 1-year high of $5.20. Institutional investors own 84.99% of the company's stock.